Literature DB >> 3069471

Renal handling of magnesium in transplanted children under cyclosporin A treatment.

F Krull1, P F Hoyer, G Offner, J Brodehl.   

Abstract

We investigated the renal handling of magnesium in 12 transplanted children under cyclosporin A treatment during the early period after transplantation. We also studied 30 children treated with cyclosporin A 2 years after renal transplantation and compared the results with those of 22 children treated with azathioprine and prednisolone 2-4 years after transplantation. Twenty-two children with chronic renal failure and 10 healthy children served as controls. During the 1st week after transplantation, the mean serum magnesium level dropped to 0.54 +/- 0.14 mmol/l and was accompanied by a high fractional magnesium clearance. During this period two patients showed generalized convulsions. After magnesium substitution, serum levels increased gradually and normalized 4 months later. Fractional magnesium clearance remained slightly elevated due to lower glomerular filtration rates. One to four years after transplantation there were no statistically significant differences in serum levels, clearance, excretion and fractional clearance of magnesium between patients treated with cyclosporin A and those receiving azathioprine. There was a linear regression between magnesium clearance and creatinine clearance and an inverse exponential correlation between fractional magnesium clearance and creatinine clearance. We conclude that cyclosporin A treatment after transplantation has no major effect on the renal handling of magnesium in kidney transplants. The observed changes in serum magnesium levels and fractional clearance are probably due to tubular cell damage early after transplantation and to high doses of furosemide.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3069471     DOI: 10.1007/bf00445925

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  26 in total

1.  Cyclosporine-associated central nervous system toxicity after renal transplantation.

Authors:  H Wilczek; O Ringden; G Tyden
Journal:  Transplantation       Date:  1985-01       Impact factor: 4.939

2.  Divalent ion excretion in chronic kidney disease: relation to degree of renal insufficiency.

Authors:  M M Popovtzer; L I Schainuck; S G Massry; C R Kleeman
Journal:  Clin Sci       Date:  1970-03       Impact factor: 6.124

3.  Renal magnesium wasting associated with amphotericin B therapy.

Authors:  C H Barton; M Pahl; N D Vaziri; T Cesario
Journal:  Am J Med       Date:  1984-09       Impact factor: 4.965

4.  Renal function after kidney transplantation in children. A comparison of conventional immunosuppression with cyclosporine.

Authors:  P F Hoyer; H P Krohn; G Offner; D J Byrd; J Brodehl; K Wonigeit; R Pichlmayr
Journal:  Transplantation       Date:  1987-04       Impact factor: 4.939

5.  Correlation of hypomagnesemia with the onset of cyclosporine-associated hypertension in marrow transplant patients.

Authors:  C H June; C B Thompson; M S Kennedy; T P Loughran; H J Deeg
Journal:  Transplantation       Date:  1986-01       Impact factor: 4.939

6.  Cyclosporine: five years' experience in cadaveric renal transplantation.

Authors:  R M Merion; D J White; S Thiru; D B Evans; R Y Calne
Journal:  N Engl J Med       Date:  1984-01-19       Impact factor: 91.245

7.  A radioimmunoassay to measure cyclosporin A in plasma and serum samples.

Authors:  P Donatsch; E Abisch; M Homberger; R Traber; M Trapp; R Voges
Journal:  J Immunoassay       Date:  1981

8.  Association between cyclosporin neurotoxicity and hypomagnesaemia.

Authors:  C B Thompson; C H June; K M Sullivan; E D Thomas
Journal:  Lancet       Date:  1984-11-17       Impact factor: 79.321

9.  Cyclosporin A in paediatric kidney transplantation.

Authors:  G Offner; P F Hoyer; J Brodehl; R Pichlmayr
Journal:  Pediatr Nephrol       Date:  1987-04       Impact factor: 3.714

10.  Effect of cyclosporine A on renal electrolyte transport: whole kidney and Henle loop study.

Authors:  R Müller-Suur; S D Davis
Journal:  Clin Nephrol       Date:  1986       Impact factor: 0.975

View more
  2 in total

Review 1.  The pathophysiology of Sandimmune (cyclosporine) in man and animals.

Authors:  J Mason
Journal:  Pediatr Nephrol       Date:  1990-09       Impact factor: 3.714

2.  Cyclosporin A treatment in children with minimal change nephrotic syndrome and focal segmental glomerulosclerosis.

Authors:  J Brodehl; M Brandis; U Helmchen; P F Hoyer; R Burghard; J H Ehrich; R B Zimmerhackl; W Klein; K Wonigeit
Journal:  Klin Wochenschr       Date:  1988-11-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.